Profile
| Metric | Value |
|---|---|
| Full Name | Arrowhead Pharmaceuticals, Inc. |
| Ticker | NASDAQ: ARWR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | arrowheadpharma.com |
| Employees | 609 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $68.06 | |
| Price, 1D Change | -5.66% | |
| $10B | ||
| - | ||
| - | ||
| 1.72 | ||
| $829M | ||
| Revenue, 1Y Change | +23,258.15% | |
| -$0.01 | ||
| EPS, 1Y Change | +99.76% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.01 | ||
| EPS Estimate | N/A | -$3.31 |
| EPS Est. Change | N/A | -27,023.77% |
| $829.45M | ||
| Revenue Estimate | N/A | $398.60M |
| Revenue Est. Change | N/A | -51.94% |
| Current Price | $68.06 | |
| Price Target | - | $82.50 |
| Price Tgt. Change | - | +21.22% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.53 | -$5.00 | -10.53% | |
| -$0.03 | -$0.01 | +63.69% | |
| -$3.31 | N/A | -27,023.77% | |
| -$4.39 | N/A | -35,883.61% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $61.60M | $3.55M | -94.24% | |
| $757.44M | $829.45M | +9.51% | |
| $398.60M | N/A | -51.94% | |
| $290.48M | N/A | -64.98% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $68.06 | |
| $34.14 | ||
| SMA 200 vs Price | -49.83% | |
| $65.10 | ||
| SMA 50 vs Price | -4.35% | |
| 1.72 | ||
| $4.17 | ||
| 52.33 | ||
| 57.13% | ||
| 72.70% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $829.45M | ||
| -$0.01 | ||
| $805.52M | ||
| 97.12% | ||
| $98.35M | ||
| 11.86% | ||
| $30.11M | ||
| 3.63% | ||
| $122.27M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 1.57 | ||
| 4.86 | ||
| 4.86 | ||
| - | ||
| - | ||
| 5.89 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 11.49 | ||
| 20.45 | ||
| 76.41 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $466.05M | ||
| $919.37M | ||
| $1.45B | ||
| $950.64M | ||
| $947.02M | ||
| $195.49M | ||
| $733.68M | ||
| $47.29M | ||
| $17.67M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $831.08M | ||
| $707.17M | ||
| $23.93M | ||
| $0.00 | ||
| $23.93M | ||
| $0.00 | ||
| $21.42M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $179.55M | ||
| -$129.29M | ||
| $74.01M | ||
| $22.67M | ||
| $156.89M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| B. Riley Securities | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler | → | |
| Morgan Stanley | → | |
| Goldman Sachs | → | |
| Chardan Capital | → | |
| Piper Sandler | → | |
| RBC Capital | → | |
| B of A Securities | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with ARWR
FAQ
What is the ticker symbol for Arrowhead Pharmaceuticals, Inc.?
The ticker symbol for Arrowhead Pharmaceuticals, Inc. is NASDAQ:ARWR
Does Arrowhead Pharmaceuticals, Inc. pay dividends?
No, Arrowhead Pharmaceuticals, Inc. does not pay dividends
What sector is Arrowhead Pharmaceuticals, Inc. in?
Arrowhead Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Arrowhead Pharmaceuticals, Inc. in?
Arrowhead Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Arrowhead Pharmaceuticals, Inc. based in?
Arrowhead Pharmaceuticals, Inc. is headquartered in United States
When did Arrowhead Pharmaceuticals, Inc. go public?
Arrowhead Pharmaceuticals, Inc. initial public offering (IPO) was on December 16, 1993
Is Arrowhead Pharmaceuticals, Inc. in the S&P 500?
No, Arrowhead Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Arrowhead Pharmaceuticals, Inc. in the NASDAQ 100?
No, Arrowhead Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Arrowhead Pharmaceuticals, Inc. in the Dow Jones?
No, Arrowhead Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Arrowhead Pharmaceuticals, Inc. last earnings report?
Arrowhead Pharmaceuticals, Inc.'s most recent earnings report was on November 25, 2025
When does Arrowhead Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Arrowhead Pharmaceuticals, Inc. is February 5, 2026
Data Sources & References
- ARWR Official Website arrowheadpharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/879407/000087940725000029/0000879407-25-000029-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/879407/000087940725000029/0000879407-25-000029-index.htm
- ARWR Profile on Yahoo Finance finance.yahoo.com/quote/ARWR
- ARWR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arwr